Soligenix
SNGX
#11002
Rank
A$11.01 M
Marketcap
A$0.51
Share price
-3.60%
Change (1 day)
-78.63%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -A$17.47 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$16.84 Million a decrease over its 2024 earnings that were of -A$13.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$17.47 Million3.71%
2025 -A$16.84 Million26.72%
2024 -A$13.29 Million22.96%
2023 -A$10.81 Million-45.74%
2022 -A$19.92 Million11.88%
2021 -A$17.8 Million-32.37%
2020 -A$26.32 Million83.18%
2019 -A$14.37 Million11.57%
2018 -A$12.88 Million19.29%
2017 -A$10.8 Million33%
2016 -A$8.12 Million-19.7%
2015 -A$10.11 Million5.16%
2014 -A$9.62 Million
2010 -A$10.85 Million26.12%
2009 -A$8.61 Million75.1%
2008 -A$4.92 Million-45.38%
2007 -A$9 Million-22.84%
2006 -A$11.66 Million66.15%
2005 -A$7.02 Million-16.65%
2004 -A$8.42 Million13.28%
2003 -A$7.43 Million-11.88%
2002 -A$8.44 Million-59.44%
2001 -A$20.79 Million378.18%
2000 -A$4.35 Million-38.53%
1999 -A$7.08 Million-18.43%
1998 -A$8.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.25 B-224,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.81 B-59,115.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.17 B-61,279.19%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-A$25.81 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$59.37 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.28 B-13,813.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-A$3.92 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.14 Billion 712.56%๐Ÿ‡บ๐Ÿ‡ธ USA